Showing results (661-670 of 829) with videos related to

Sort By:
Pageof 83
The Journal of Clinical Investigation|January 22, 2020
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoproteinJing Cheng, Linda R Klei, Nathaniel E Hubel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2019
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10Jame Abraham, Albert J Montero, Rachel C Jankowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Journal of Medicinal Chemistry|July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsSimon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.
Oncogene|November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinomaLesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Nature Communications|July 23, 2020
Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growthL M Schiffmann, J P Werthenbach, F Heintges-Kleinhofer, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Cancer Research|December 21, 2017
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast CancerPrasanna Ekambaram, Jia-Ying Lloyd Lee, Nathaniel E Hubel, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Human Pathology|June 18, 2026
A Report of Thirteen Non-Conventional FLCN-Mutated (Renal) Tumors (FMT) and a Discussion of Proposed Diagnostic Criteria, Convergent FLCN/TFEB and FLCN/MITF E318K Signaling, and FLCN immunohistochemistrySounak Gupta, Rosalie M Sterner, Hisashi Hasumi, et al.
Pageof 83